These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33895991)

  • 21. Responding to opioid overdose in Rhode Island: where the medical community has gone and where we need to go.
    Green TC; Bratberg J; Dauria EF; Rich JD
    R I Med J (2013); 2014 Oct; 97(10):29-33. PubMed ID: 25271657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postoperative opioid prescribing: Getting it RIGHTT.
    Yorkgitis BK; Brat GA
    Am J Surg; 2018 Apr; 215(4):707-711. PubMed ID: 29454483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of opioid prescribing through the sharing of individual physician opioid prescribing practices.
    Boyle KL; Cary C; Dizitzer Y; Novack V; Jagminas L; Smulowitz PB
    Am J Emerg Med; 2019 Jan; 37(1):118-122. PubMed ID: 30343961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opioid medication prescribing in Queensland, 1997-2018: a population study.
    Adewumi AD; Maravilla JC; Alati R; Hollingworth SA; Hu X; Loveday B; Connor J
    Med J Aust; 2021 Aug; 215(3):137-138. PubMed ID: 34096073
    [No Abstract]   [Full Text] [Related]  

  • 25. Implementation evaluation of academic detailing on naloxone prescribing trends at the United States Veterans Health Administration.
    Bounthavong M; Devine EB; Christopher MLD; Harvey MA; Veenstra DL; Basu A
    Health Serv Res; 2019 Oct; 54(5):1055-1064. PubMed ID: 31313839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concentration of Patient Care Among Buprenorphine-Prescribing Clinicians in the US.
    Stein BD; Saloner B; Schuler MS; Gurvey J; Sorbero M; Gordon AJ
    JAMA; 2021 Jun; 325(21):2206-2208. PubMed ID: 34061152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk Stratification for Naloxone Rescue Kit Interventions at a Veterans Affairs Teaching Hospital.
    Rozea HN; Mitchell BG; Miller LJ
    J Clin Psychopharmacol; 2020; 40(5):513-515. PubMed ID: 32796390
    [No Abstract]   [Full Text] [Related]  

  • 28. Implementing an overdose education and naloxone distribution program in a health system.
    Devries J; Rafie S; Polston G
    J Am Pharm Assoc (2003); 2017; 57(2S):S154-S160. PubMed ID: 28233681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naloxone prescriptions following emergency department encounters for opioid use disorder, overdose, or withdrawal.
    Kilaru AS; Liu M; Gupta R; Perrone J; Delgado MK; Meisel ZF; Lowenstein M
    Am J Emerg Med; 2021 Sep; 47():154-157. PubMed ID: 33812332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. State Emergency Department Opioid Guidelines: Current Status.
    Broida RI; Gronowski T; Kalnow AF; Little AG; Lloyd CM
    West J Emerg Med; 2017 Apr; 18(3):340-344. PubMed ID: 28435482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of an emergency department opioid prescribing guideline on emergency physician behaviour and incidence of overdose in the Saskatoon Health Region: a retrospective pre-post implementation analysis.
    Hartmann RJ; Elder JD; Terrett LA
    CMAJ Open; 2021; 9(1):E79-E86. PubMed ID: 33514601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Avoiding an opioid crisis in the UK.
    Levy N; Mills P; Fawcett WJ
    BMJ; 2019 Mar; 364():l1033. PubMed ID: 30858226
    [No Abstract]   [Full Text] [Related]  

  • 33. Naloxone and Buprenorphine Prescribing Following US Emergency Department Visits for Suspected Opioid Overdose: August 2019 to April 2021.
    Chua KP; Dahlem CHY; Nguyen TD; Brummett CM; Conti RM; Bohnert AS; Dora-Laskey AD; Kocher KE
    Ann Emerg Med; 2022 Mar; 79(3):225-236. PubMed ID: 34802772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of Filled Buprenorphine Prescriptions for Opioid Use Disorder During the Coronavirus Disease 2019 Pandemic.
    Nguyen TD; Gupta S; Ziedan E; Simon KI; Alexander GC; Saloner B; Stein BD
    JAMA Intern Med; 2021 Apr; 181(4):562-565. PubMed ID: 33346795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High volume of opioid prescribing and the apparent consequences.
    Mendes A
    Br J Community Nurs; 2020 Jan; 25(1):48-49. PubMed ID: 31874083
    [No Abstract]   [Full Text] [Related]  

  • 36. Opiate addiction and overdose: experiences, attitudes, and appetite for community naloxone provision.
    Barry T; Klimas J; Tobin H; Egan M; Bury G
    Br J Gen Pract; 2017 Apr; 67(657):e267-e273. PubMed ID: 28246098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary Care Patient Experience with Naloxone Prescription.
    Behar E; Rowe C; Santos GM; Murphy S; Coffin PO
    Ann Fam Med; 2016 Sep; 14(5):431-6. PubMed ID: 27621159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opioid Prescribing Behaviors - Prescription Behavior Surveillance System, 11 States, 2010-2016.
    Strickler GK; Kreiner PW; Halpin JF; Doyle E; Paulozzi LJ
    MMWR Surveill Summ; 2020 Jan; 69(1):1-14. PubMed ID: 31999681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proceedings from Bridging Health Disparities to Address the Opioid Epidemic: A Symposium at the Warren Alpert Medical School of Brown University.
    Dumenco L; Monteiro K; Mello M; Collins S; Operario D; Scanlan K; Dollase R; George P
    R I Med J (2013); 2017 Apr; 100(4):16-18. PubMed ID: 28375414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inappropriate opioid prescribing practices: A narrative review.
    Kim B; Nolan S; Beaulieu T; Shalansky S; Ti L
    Am J Health Syst Pharm; 2019 Aug; 76(16):1231-1237. PubMed ID: 31251321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.